Glaukos (GKOS)
(Delayed Data from NYSE)
$100.93 USD
-0.17 (-0.17%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $100.98 +0.05 (0.05%) 7:48 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Income Statements
Fiscal Year end for Glaukos Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 315 | 283 | 294 | 225 | 237 |
Cost Of Goods | 76 | 69 | 67 | 92 | 39 |
Gross Profit | 239 | 214 | 227 | 133 | 198 |
Selling & Adminstrative & Depr. & Amort Expenses | 368 | 296 | 260 | 257 | 249 |
Income After Depreciation & Amortization | -129 | -82 | -33 | -124 | -50 |
Non-Operating Income | 9 | -2 | -3 | 5 | 3 |
Interest Expense | 14 | 14 | 13 | 14 | 3 |
Pretax Income | -134 | -98 | -49 | -132 | -50 |
Income Taxes | 1 | 1 | 0 | -12 | -65 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -135 | -99 | -50 | -120 | 15 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -135 | -99 | -50 | -120 | 15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -91 | -44 | 4 | -58 | -41 |
Depreciation & Amortization (Cash Flow) | 38 | 38 | 37 | 66 | 10 |
Income After Depreciation & Amortization | -129 | -82 | -33 | -124 | -50 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.43 | 47.44 | 46.42 | 44.50 | 41.15 |
Diluted EPS Before Non-Recurring Items | -2.27 | -2.18 | -0.83 | -1.15 | -0.10 |
Diluted Net EPS (GAAP) | -2.78 | -2.09 | -1.07 | -2.70 | 0.37 |
Fiscal Year end for Glaukos Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 82.36 | 78.05 | 80.40 | 73.90 |
Cost Of Goods | NA | 18.89 | 18.51 | 20.10 | 18.07 |
Gross Profit | NA | 63.47 | 59.54 | 60.30 | 55.83 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 102.09 | 87.55 | 89.37 | 88.82 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -38.62 | -28.01 | -29.07 | -32.99 |
Non-Operating Income | NA | 5.33 | 1.00 | 0.10 | 2.18 |
Interest Expense | NA | 3.43 | 3.40 | 3.40 | 3.41 |
Pretax Income | NA | -36.72 | -30.41 | -32.38 | -34.23 |
Income Taxes | NA | 0.06 | 0.04 | 0.44 | 0.40 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -36.78 | -30.44 | -32.81 | -34.63 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -36.78 | -30.44 | -32.81 | -34.63 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 48.88 | 48.68 | 48.28 | 47.88 |
Diluted EPS Before Non-Recurring Items | NA | -0.63 | -0.50 | -0.55 | -0.59 |
Diluted Net EPS (GAAP) | NA | -0.75 | -0.63 | -0.68 | -0.72 |